AMANDA BECKHAM: Open Payments
NPI 1154816999 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 11 payments from 6 companies in 2025. Trend: 2023 $336 · 2024 $207 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $166 |
| Astellas Pharma US Inc | 3 | $68 |
| Lilly USA, LLC | 2 | $55 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Neos Therapeutics, LP | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: Wegovy, Veozah, ZEPBOUND, Ozempic, Jornay PM, Adzenys XR-ODT.
Industry payments across IN — which companies pay providers there.
